Mohamed Kharfan-Dabaja

Mohamed Kharfan-Dabaja: Great Update on Management of CD30+ non-Hodgkin Lymphomas

Mohamed Kharfan-Dabaja, Vice Chair of Hematology and Director of Blood Marrow and Transplantation and Cellular Therapies at Mayo Clinic Comprehensive Cancer Center, shared a post on X:

“Great update on management of CD30+ non-Hodgkin lymphomas by Madiha Iqbal at the Mayo Clinic 34th Annual Hematology-Oncology Reviews in Amelia Island, FL.”

Mohamed Kharfan-Dabaja: Great Update on Management of CD30+ non-Hodgkin Lymphomas

More posts featuring Non-Hodgkin Lymphomas.